Advertisement

Metabolic Brain Disease

, Volume 20, Issue 4, pp 393–398 | Cite as

Chronic Systemic Endotoxin Exposure: An Animal Model in Experimental Hepatic Encephalopathy

  • Kai O. Lindros
  • Harri A. Järveläinen
Article

Abstract

Plasma levels of gut-derived endotoxins (lipopolysaccharides, LPS) are often elevated in cirrhotics and are thought to contribute to hepatic encephalopathy. Circulating LPS activates macrophages to produce tumor necrosis factor ά (TNF-ά) and other potentially cytotoxic proinflammatory mediators. A pathogenic role forendotoxins is supported by studies showing that treatment with Lactobacillusor antibiotics, both of which reduce LPS-producingintestinal Gram-negative bacteria, alleviates experimental liver damage. To mimic the “leaky gut” syndrome with endotoxin translocation into the circulation in cirrhotics, a new animal model was developed. Rats were chronically exposed to ethanol and for the four last weeks also infused with endotoxin into the jugular vein from subcutaneously implanted osmotic minipumps. Animals receiving endotoxin had elevated hepatic expression of both pro- and anti-inflammatory cytokines, but compared to ethanol treatment alone hepatic steatosis and inflammatory changes were only marginally increased. This demonstrates marked endotoxin tolerance, probably as a consequence of a counteracting anti-inflammatory cytokine response. The role of gut-derived endotoxin in hepatic encephalopathy has recently received considerable attention. To further delineate the role and actions of endotoxin and its extrahepatic effects, studies applying both acute challenge and chronic infusion seem warranted. The chronic endotoxin model, mimicking the “leaky gut,” may best be combined with more robust ways to impair liver function, such as carbon tetrachloride treatment, bile duct ligation, or galactosamine administration.

Keywords

Endotoxin infusion cytokines animal model Kupffer cells gut leakage liver damage 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adachi, Y., Moore, L.E., Bradford, B.U., Gao, W., and Thurman, R.G. (1995). Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218–224.PubMedGoogle Scholar
  2. Ali, M.V., and Nolan, J.P. (1967). Alcohol induced depression of reticuloendothelial function in the rat. J. Lab. Clin. Med. 70:295–301.PubMedGoogle Scholar
  3. Arai, T., Hiromatsu, K., Kobayashi, N., Takano, M., Ishida, H., Nimura, Y., and Yoshikai, Y. (1995). IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155:5743–5749.PubMedGoogle Scholar
  4. Bauer, T.M., Schwacha, H., Steinbruckner, B., Brinkmann, F.E., Ditzen, A.K., Aponte, J.J., Pelz, K., Berger, D., Kist, M., and Blum, H.E. (2002). Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am. J. Gastroenterol. 97:2364–2370.PubMedCrossRefGoogle Scholar
  5. Bickel, U., Grave, B., Kang, Y.S., del Rey, A., and Voigt, K. (1998). No increase in blood–brain barrier permeability after intraperitoneal injection of endotoxin in the rat. J. Neuroimmunol. 85:131–136.PubMedCrossRefGoogle Scholar
  6. Bigatello, L.M., Broitman, S.A., Fattori, L., Di Paoli, M., Pontello, M., Bevilacqua, G., and Nespoli, A. (1987). Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 82:11–15.PubMedGoogle Scholar
  7. Bjarnason, I., Peters, T.J., and Wise, R.J. (1984). The leaky gut of alcoholism: Possible route of entry for toxic compounds. Lancet 1(8370):179–182.PubMedGoogle Scholar
  8. Bode, C., Kugler, V., and Bode, J.C.J. (1987). Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 4:8–14.PubMedCrossRefGoogle Scholar
  9. Chiva, M., Soriano, G., Rochat, I., Peralta, C., Rochat, F., Llovet, T., Mirelis, B., Schiffrin, E.J., Guarner, C., and Balanzo, J. (2002). Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J. Hepatol. 37:456–462.PubMedCrossRefGoogle Scholar
  10. Clausen, M.R., and Mortensen, P.B. (1997). Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53:930–942.PubMedCrossRefGoogle Scholar
  11. de Vries, H.E., Blom-Roosemalen, M.C., van Oosten, M., de Boer, A.G., van Berkel, T.J., Breimer, D.D., and Kuiper, J. (1996). The influence of cytokines on the integrity of the blood–brain barrier in vitro. J. Neuroimmunol. 64:37–43.PubMedGoogle Scholar
  12. Hagan, P., Poole, S., and Bristow, A.F. (1993). Endotoxin-stimulated production of rat hypothalamic interleukin 1β in vivo and in vitro, measured by specific immunoradiometric assay. J. Mol. Endocrinol. 11:31–36.PubMedCrossRefGoogle Scholar
  13. Hill, D.B., D'Souza, N.B., Lee, E.Y., Burikhanov, R., Deaciuc, I.V., and de Villiers, W.J. (2002). A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin. Exp. Res. 26:74–82.PubMedGoogle Scholar
  14. Järveläinen, H.A., Fang, C., Ingelman-Sundberg, M., and Lindros, K.O. (1999). Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 29:1503–1510.PubMedGoogle Scholar
  15. Järveläinen, H.A., Oinonen, T., and Lindros, K.O. (1997). Alcohol-induced expression of the CD14 endotoxin receptor protein in rat Kupffer cells. Alcohol Clin. Exp. Res. 21:1547–1551.PubMedGoogle Scholar
  16. Järveläinen, H.A., Orpana, A., Perola, M., Savolainen, V.T., Karhunen, P.J., and Lindros, K.O. (2001). Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33:1148–1153.PubMedGoogle Scholar
  17. Lindros, K.O., and Järveläinen, H.A. (1998). A new oral low-carbohydrate alcohol liquid diet producing liver lesions: A preliminary account. Alcohol Alcohol. 33:347–353.PubMedGoogle Scholar
  18. Liu, Q., Duan, Z.P., Ha, da K., Bengmark, S., Kurtovic, J., and Riordan, S.M. (2004). Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441–1449.PubMedCrossRefGoogle Scholar
  19. Mathurin, P., Deng, Q.G., Keshavarzian, A., Choudhary, S., Holmes, E.W., and Tsukamoto, H. (2000). Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32:1008–1017.PubMedCrossRefGoogle Scholar
  20. Nanji, A.A., Khettry, U., and Sadrzadeh, S.M. (1994). Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc. Soc. Exp. Biol. Med. 205:243–247.PubMedGoogle Scholar
  21. Nayyar, R.P., Hurley, R.M., Goto, M., and Zeller, W.P. (1989). Microvascular endothelium: A major target site of endotoxin induced injury in 10 day old rat. J. Exp. Pathol. 4:57–67.PubMedGoogle Scholar
  22. Nolan, J.P. (1989). Intestinal endotoxins as mediators of hepatic injury—an idea whose time has come again. Hepatology 10:887–891.PubMedGoogle Scholar
  23. Odeh, M. (1994). Endotoxin and tumor necrosis factor-a in the pathogenesis of hepatic encephalopathy. J. Clin. Gastroenterol. 19:146–153.PubMedGoogle Scholar
  24. Odeh, M., Sabo, E., Srugo, I., and Oliven, A. (2004). Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int. 24:110–116.PubMedCrossRefGoogle Scholar
  25. Redl, H., Bahrami, S., Schlag, G., and Traber, D.L. (1993). Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187:330–345.PubMedGoogle Scholar
  26. Solga, S.F., and Diehl, A.M. (2004). Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 39:1197–1200.PubMedCrossRefGoogle Scholar
  27. Tamai, H., Horie, Y., Kato, S., Yokoyama, H., and Ishii, H. (2002). Long-term ethanol feeding enhances susceptibility of the liver to orally administered lipopolysaccharides in rats. Alcohol Clin. Exp. Res. 26:75S–80S.PubMedGoogle Scholar
  28. Tarao, K., So, K., Moroi, T., Ikeuchi, T., and Suyama, T. (1977). Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance. Gastroenterology 73:539–542.PubMedGoogle Scholar
  29. Triger, D.R., Boyer, T.D., and Levin, J. (1978). Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut 19:935–939.PubMedGoogle Scholar
  30. Vilstrup, H. (2003). Cirrhosis and bacterial infections. Rom. J. Gastroenterol. 12:297–302.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  1. 1.National Public Health Institute, Alcohol Research CenterHelsinkiFinland
  2. 2.Department of Food and Environmental Hygiene, Faculty of Veterinary MedicineUniversity of HelsinkiFinland
  3. 3.National Public Health Institute, Alcohol Research CenterHelsinkiFinland

Personalised recommendations